SAN FRANCISCO, May 20, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges QuidelOrtho Corporation (NASDAQ:QDEL) investors who suffered substantial losses to submit your losses now.
Class Period: Feb. 18, 2022 – Apr. 1, 2024 | |
Lead Plaintiff Deadline: June 11, 2024 | |
Visit: www.hbsslaw.com/investor-fraud/QDEL | |
Contact the Firm Now: QDEL@hbsslaw.com | |
844-916-0895 | |
QuidelOrtho Corporation (NASDAQ:QDEL) Securities Class Action:
The litigation is focused on the propriety of QuidelOrtho's past assurances about its preparedness to maintain a stable high margin revenue stream from its respiratory business in the face of the COVID-19 pandemic becoming an endemic and about its FDA submission for its purported "next flagship product" (the "Savanna RVP4 Test") being "on track."
The complaint alleges QuidelOrtho misled investors by making statements that were false and misleading because it knew or deliberately disregarded that: (1) it sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell ...
QDEL) Class Action Filed After QDEL Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman HAGENS BERMAN Encourages QDEL Investors Who Suffered Substantial Losses to Contact Firm>Full story available on Benzinga.com